Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction

NCT01211522 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT01211522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01211522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
December 14, 2011
Completion date
July 19, 2018
Enrollment
566 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, impaired cognition, long term psychologic disorders